# GS Plastic Optics awarded contract to produce optical components for LightDeck Diagnostics

GS Plastic Optics (GSPO) has been awarded a contract to produce optical components (waveguides) for LightDeck Diagnostics' COVID-19 antibody testing platform. GSPO will invest $5 million in an 8,000 sq. ft. expansion of its Rochester, NY facility, creating 15 jobs, to support production of one million waveguides per month by Fall 2022.

- Type: Contract
- Announced: 2021-09-21
- Where: Rochester, New York, United States
- Value: $5.00M
- Jobs: 15
- Status: announced
- Capacity: one million waveguides per month
- Products: precision polymer optics, waveguides for COVID-19 antibody testing
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GS Plastic Optics](https://endata.com/companies/57865.md)
- [U.S. Department of Health and Human Services](https://endata.com/companies/46441.md) (partner)
- [GS Plastic Optics](https://endata.com/companies/57865.md) (supplier)
- [LightDeck Diagnostics](https://endata.com/companies/57866.md) (customer)

## Sources

- [webwire.com](https://www.webwire.com/ViewPressRel.asp?aId=279370), 2021-09-21: "Today more than ever, our goal is to support the medical community in their great strides to improve the healthcare for our nation."
- [newyorkphotonics.org](https://newyorkphotonics.org/gs-plastic-optics-awarded-contract-with-lightdeck-diagnostics-for-lab-quality-5-minute-covid-19-test-production/), 2021-09-22: "Today more than ever, our goal is to support the medical community in their great strides to improve the healthcare for our nation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.